Company dossier
Vimta Labs Limited
Current pulse
Pattern-matched earnings signal
Double-digit revenue, PBT and PAT growth support a positive result read. HOLD reflects flat sequential growth, a softer operating margin excluding other income, higher depreciation and missing utilization, order-book and cash-flow evidence.
Double-digit YoY growth is constructive, while flat sequential revenue and capacity returns still need proof.
New laboratory capacity can raise depreciation before utilization and revenue mature.
Q1 FY2027 earnings call
Dossier map
Double-digit YoY growth is constructive, while flat sequential revenue and capacity returns still need proof.
Revenue ₹109.074 Cr | PAT ₹21.042 Cr | EBIT margin 37.7%
This layer will track order book, execution runway, capex, capacity and pipeline as company-specific fields are populated.
Management commentary and tone shift will sit here.
Healthcare needs explicit government, rates, commodity, FX and demand sensitivity mapping.
New laboratory capacity can raise depreciation before utilization and revenue mature.